Overview

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Status:
Completed
Trial end date:
2018-04-30
Target enrollment:
Participant gender:
Summary
This was a multicenter, randomized, multiple-dose, laboratory-blinded, open-label, 2-arm, parallel-arm study in subjects with moderate acne vulgaris.
Phase:
Phase 2
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Nicotinic Acids
Tazarotene